Search

everythinglearnresearchcommunity

for

Search:↓

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Clonally expanded CD8+ T cells cause alopecia areata.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Alopecia areata patients have higher IFN-γ and low vitamin D3 levels.

Thymol-loaded nanoparticles are a promising, natural treatment for acne that avoids antibiotics and preserves healthy skin bacteria.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Levothyroxine is less effective in men with early-onset male-pattern baldness.

Consider TFI in facial hypopigmentation diagnoses and confirm with a biopsy.

Timely diagnosis and treatment of complex autoimmune diseases like APS2 are crucial to prevent complications and improve life quality.

Botulinum toxin A effectively treated a man's facial cysts with no side effects and lasting results.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

A man developed myasthenia gravis after alopecia areata, and treatment improved his symptoms and stopped hair loss.

Methimazole can cause severe low platelet count in Graves' disease patients, so monitoring and alternative treatments are important.

People with alopecia areata have different blood markers that suggest inflammation and immune system issues compared to healthy individuals.

Botox can help prevent hair loss by blocking cell death in scalp cells.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Betamethasone can effectively treat alopecia areata.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Generalized trichoepitheliomas with hair loss may indicate myasthenia gravis.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Thymosin β4 promotes hair growth by activating stem cells in hair follicles.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Waldenstrom’s Macroglobulinaemia can mimic multiple myeloma, so accurate diagnosis is crucial.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

PBMCsec can help reduce and improve thick skin scars.

The dense fine speckled pattern in ANA tests is common in autoimmune diseases, challenging previous beliefs that it was unrelated.